Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Subarachnoid Hemorrhage | 2 | 2020 | 42 | 0.770 |
Why?
|
| Hydrocephalus | 1 | 2020 | 17 | 0.670 |
Why?
|
| Nitric Oxide | 1 | 2018 | 124 | 0.530 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 71 | 0.530 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2016 | 2 | 0.500 |
Why?
|
| Stroke | 4 | 2016 | 731 | 0.480 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2016 | 76 | 0.470 |
Why?
|
| Mitochondria | 1 | 2018 | 298 | 0.460 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2022 | 74 | 0.420 |
Why?
|
| Brain Injuries | 4 | 2015 | 76 | 0.410 |
Why?
|
| Dura Mater | 1 | 2008 | 9 | 0.280 |
Why?
|
| Decompression, Surgical | 1 | 2008 | 22 | 0.280 |
Why?
|
| Middle Cerebral Artery | 1 | 2008 | 27 | 0.280 |
Why?
|
| Cerebral Infarction | 1 | 2008 | 47 | 0.280 |
Why?
|
| Thrombolytic Therapy | 2 | 2019 | 129 | 0.270 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2007 | 27 | 0.260 |
Why?
|
| Intensive Care Units | 2 | 2022 | 215 | 0.260 |
Why?
|
| Glasgow Coma Scale | 4 | 2022 | 19 | 0.230 |
Why?
|
| Brain Ischemia | 2 | 2019 | 262 | 0.230 |
Why?
|
| Humans | 18 | 2022 | 40217 | 0.200 |
Why?
|
| Middle Aged | 12 | 2021 | 10090 | 0.180 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2021 | 3 | 0.180 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2021 | 5 | 0.180 |
Why?
|
| Retrospective Studies | 5 | 2020 | 3138 | 0.180 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 51 | 0.170 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2020 | 10 | 0.170 |
Why?
|
| Trauma Severity Indices | 2 | 2018 | 14 | 0.170 |
Why?
|
| Dexamethasone | 1 | 2020 | 81 | 0.160 |
Why?
|
| Bed Rest | 1 | 2019 | 8 | 0.160 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2019 | 5 | 0.160 |
Why?
|
| Cohort Studies | 5 | 2022 | 1479 | 0.160 |
Why?
|
| Cerebral Angiography | 1 | 2019 | 138 | 0.150 |
Why?
|
| Biopsy | 1 | 2019 | 228 | 0.150 |
Why?
|
| Glasgow Outcome Scale | 2 | 2016 | 8 | 0.150 |
Why?
|
| Diffuse Axonal Injury | 1 | 2018 | 4 | 0.140 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2018 | 5 | 0.140 |
Why?
|
| Brain | 2 | 2019 | 1029 | 0.140 |
Why?
|
| Encephalocele | 2 | 2015 | 12 | 0.140 |
Why?
|
| Brain Edema | 2 | 2015 | 15 | 0.140 |
Why?
|
| Aged | 9 | 2019 | 8182 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 663 | 0.130 |
Why?
|
| Male | 12 | 2021 | 18271 | 0.130 |
Why?
|
| Adult | 9 | 2022 | 10255 | 0.130 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 38 | 0.130 |
Why?
|
| Models, Neurological | 1 | 2016 | 59 | 0.130 |
Why?
|
| Brain Death | 1 | 2015 | 6 | 0.120 |
Why?
|
| Blood Gas Analysis | 1 | 2015 | 17 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 45 | 0.120 |
Why?
|
| Apnea | 1 | 2015 | 26 | 0.120 |
Why?
|
| Female | 11 | 2019 | 20392 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2019 | 2863 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 106 | 0.120 |
Why?
|
| Embolism, Paradoxical | 1 | 2015 | 5 | 0.120 |
Why?
|
| Thrombophilia | 1 | 2015 | 10 | 0.120 |
Why?
|
| Foramen Ovale, Patent | 1 | 2015 | 6 | 0.120 |
Why?
|
| Renal Replacement Therapy | 1 | 2015 | 17 | 0.120 |
Why?
|
| Hemofiltration | 1 | 2015 | 14 | 0.110 |
Why?
|
| Dantrolene | 1 | 2014 | 8 | 0.110 |
Why?
|
| Muscle Relaxants, Central | 1 | 2014 | 12 | 0.110 |
Why?
|
| Vasospasm, Intracranial | 1 | 2014 | 15 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 65 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 63 | 0.110 |
Why?
|
| Leukoaraiosis | 1 | 2014 | 39 | 0.110 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 582 | 0.110 |
Why?
|
| White Matter | 1 | 2014 | 76 | 0.110 |
Why?
|
| Prognosis | 3 | 2022 | 921 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 832 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2021 | 1958 | 0.070 |
Why?
|
| Speech Disorders | 1 | 2008 | 10 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2008 | 62 | 0.070 |
Why?
|
| Hospital Mortality | 2 | 2022 | 459 | 0.060 |
Why?
|
| Risk | 1 | 2006 | 248 | 0.060 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2007 | 71 | 0.060 |
Why?
|
| Oxygen | 1 | 2007 | 192 | 0.060 |
Why?
|
| Fatal Outcome | 2 | 2015 | 69 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 597 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 3136 | 0.060 |
Why?
|
| Disease Progression | 1 | 2007 | 541 | 0.060 |
Why?
|
| Incidence | 1 | 2006 | 773 | 0.060 |
Why?
|
| Animals | 1 | 2018 | 16893 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2019 | 10 | 0.040 |
Why?
|
| Echocardiography | 1 | 2021 | 254 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 59 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2877 | 0.040 |
Why?
|
| Survival Rate | 1 | 2018 | 452 | 0.030 |
Why?
|
| United States | 1 | 2006 | 4886 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 7 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2015 | 59 | 0.030 |
Why?
|
| Respiration | 1 | 2015 | 49 | 0.030 |
Why?
|
| Hypoxia | 1 | 2015 | 61 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 2422 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 966 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 870 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 367 | 0.030 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hypotension | 1 | 2013 | 21 | 0.030 |
Why?
|
| Fever | 1 | 2013 | 39 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 50 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2013 | 18 | 0.030 |
Why?
|
| Massachusetts | 1 | 2018 | 1701 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 43 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2013 | 92 | 0.020 |
Why?
|
| Cross Infection | 1 | 2013 | 78 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 364 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 870 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 585 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1069 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 813 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 3141 | 0.020 |
Why?
|
| Adolescent | 1 | 2015 | 4034 | 0.020 |
Why?
|